New Gene Therapy to Fix Dystrophin Deficiency in DMD Shows Promise in Mice, Study Shows – Muscular Dystrophy News
|
New Gene Therapy to Fix Dystrophin Deficiency in DMD Shows Promise in Mice, Study Shows
Muscular Dystrophy News Researchers at the University of Missouri have developed a new method to efficiently deliver the correct form of dystrophin gene to muscles as a way to correct the faulty gene that characterizes Duchenne muscular dystrophy (DMD), a mouse study shows. |
